期刊文献+

肺癌患者^(18)F-FDG PET/CT和CT大体靶区差异的系统分析 被引量:1

Difference in gross target volume derived from ^(18)F-FDG PET/CT and from CT images for lung cancer:a systematic analysis
下载PDF
导出
摘要 目的探讨 PET/CT 和 CT 大体靶区(GTV)在肺癌患者之间、观察者之间、资料来源之间的差异以及 GTV 亚组之间的统计分析方法。方法通过检索 PUBMED 和 EMBASE,得到在肺癌患者中用 PET/CT 勾画 GTV 的文献,针对 GTV 进行统计分析。结果在2006年3月的检索中,共得到4篇相关文献。4项研究间的统计分析表明,虽然4项研究的 GTV_(CT)差异有统计学意义(F=9.43,P<0.01),但 GTV_(PET/CT)间差异无统计学意义(F=1.83,P=0.149)。对 Steenbakkers 等的研究分析表明,GTV_(PET/CT)和 GTV_(CT)的绝对差值在观察者之间(F=3.93,P<0.01),GTV_(PET/CT)和 GTV_(CT)之间(F=29.31,P<0.01)的差异均有统计学意义。GTV_(PET/CT)和 GTV_(CT)的绝对差值和一致性分别与"相对金标准"有较好的相关性(偏相关系数分别为0.384和0.506,P 均<0.01)。结论 GTV_(PET/CT)和 GTV_(CT)在患者、观察者、资料来源之间差异有统计学意义。PET/CT 可以改变常规放疗计划,减少观察者勾画靶区的差异。另外,硬件融合图像 GTV 的离散程度比软件融合图像小,其差异有统计学意义。 Objective The aim of this study was to analyze the diversity of gross target volume (GTV) PET/CT and GTVCT in different patients, observers and studies, and to find a statistical method to identify the discrepancy among subsets of GTV. Methods The articles in PUBMED and EMBASE that defined target volume based on PET/CT images among lung cancer patients were reviewed and analyzed statistically. Results Four relative papers were found in the searches ( till March 2006). The statistical analysis of the 4 studies had shown that significant difference of GTVcT existed among studies ( F = 9.43, P 〈 0.01 ), but GTVPET/CT remitted (F = 1.83 ,P = 0. 149). In the data of Steenbakkers et al, significant differences existed among observers ( F = 3.93, P 〈 0.01 ) in both GTVPET/CT and GTVCT ( F = 29.31 , P 〈 0.01 ). Absolute diversity and concordance were better with " relative golden standard" ( partial correlations were 0. 384 and 0. 506, respectively, both P 〈 0.01 ). Conclusions There was significant difference of GTVPET/CT and GTVCT among patients, observers or studies. PET/CT could significantly change the radiotherapy planning, reduce the variance among observers. In addition, the GTV on hardware fusion images, compared with software fusion, had a narrow range with a significant statistical difference.
出处 《中华核医学杂志》 CAS CSCD 北大核心 2007年第5期300-302,共3页 Chinese Journal of Nuclear Medicine
关键词 肺肿瘤 体层摄影术 发射型计算机 体层摄影术 X线计算机 脱氧葡萄糖 质量控制 Lung neoplasms Tomography, emission-computed Tomography, X-ray computed Deoxyglucose Quality control
  • 相关文献

参考文献10

  • 1司宏伟,耿建华,陈盛祖.PET-CT在调强适形放疗中的临床应用[J].国外医学(放射医学核医学分册),2005,29(5):223-226. 被引量:6
  • 2党亚萍,张雪林,陈盛祖,韩良辅,王胜军.PET/CT显像在恶性肿瘤治疗中的临床意义[J].中华核医学杂志,2005,25(4):219-221. 被引量:8
  • 3屈婉莹,周前.PET在肿瘤学中的应用前景[J].中华核医学杂志,2003,23(S1):5-7. 被引量:4
  • 4Brianzoni E, Rossi G, Ancidei S, et al. Radiotherapy planning: PET/CT scanner performances in the definition of gross tumour volume and clinical target volume. Eur J Nucl Med Mol Imaging, 2005, 32: 1392-1399.
  • 5Steenbakkers RJ, Duppen JC, Fitton I, et al. Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis. Int J Radiat Oncol Biol Phys, 2006, 64 : 435-448.
  • 6Bradley J, Thorstad WL, Mutic S, et al. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys, 2004, 59: 78-86.
  • 7Chetty IJ, Fernando S, Kessler ML, et al. Monte Carlo-based lung cancer treatment planning incorporating PET-defined target volumes. J Appl Clin Med Phys, 2005, 6: 65-76.
  • 8Ashamalla H, Rafla S, Parikh K, et al. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer. Int J Radiat Oncol Biol Phys, 2005, 63: 1016-1023.
  • 9Fox JL, Rengan R, O'Meara W, et al. Does registration of PET and planning CT images decrease interobserver and intraobserver variation in delineating tumor volumes for non-small-cell lung cancer? Int J Radiat Oncol Biol Phys, 2005, 62 : 70-75.
  • 10Kim JH, Czemin J, Allen-Auerbach MS, et al. Comparison between ^18F-FDG PET, in-line PET/CT, and software fusion for restaging of recurrent colorectal cancer. J Nucl Med, 2005, 46: 587-595.

二级参考文献31

  • 1Antoch G, Vogt FM, Freudenberg LS, et al. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology.JAMA, 2003, 290: 3199-3206.
  • 2Blomqvist L, Torkzad MR. Whole-body imaging with MRI or PET/CT: the future for single-modality imaging in oncology? JAMA, 2003,290: 3248-3249.
  • 3Bar-Shalom R, Yefremov N, Guralnik L, et al. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med, 2003, 44: 1200-1209.
  • 4Wahl RL. Why nearly all PET of abdominal and pelvic cancers will be performed as PET/CT. J Nucl Med, 2004, 45: 82S-95S.
  • 5Goerres GW, von Schulthess GK, Steinert HC. Why most PET of lung and head-and-neck cancer will be PET/CT. J Nucl Med, 2004,45: 66S-71S.
  • 60llenberger GP, Weder W, yon Schulthess GK, et al. Staging of lung cancer with integrated PET/CT. N Engl J Med, 2004, 350: 86-87.
  • 7Metser U, Lerman H, Blank A, et al. Malignant involvement of the spine: assessment by 18F-FDG PET/CT. J Nucl Med, 2004, 45:279-284.
  • 8Schoder H, Yeung HWD, Gonen M, et al. Head and neck cancer:clinical usefulness and accuracy of PET/CT image fusion. Radiology,2004, 231: 65-72.
  • 9Scarfoue C, Lavely WC, Cmelak AJ, et al. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dinensional PET and CT imaging. J Nucl Med, 2004, 45: 543-552.
  • 10Weder W, Schmid RA, Bruchhaus H, et al. Detection of extra thoracic metastases by positron emission tomography in lung cancer[J]. Ann Thorac Surg, 1998, 66(3): 886-892.

共引文献15

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部